Laleh Ardeshirpour, MD, is a pediatric endocrinologist at Connecticut Children’s. Dr. Ardeshirpour’s clinical interests include Growth and Bone Disorders in Pediatrics. In her free time, Dr. Ardeshirpour enjoys traveling and cooking.

Education

TEHRAN UNIVERSITY, IRAN

Residency

University of Medicine and Dentistry of New Jersey

Children's Medical Center Iran

Fellowship

Johns Hopkins Hospital

Yale-New Haven Children's Hospital

American Board of Pediatrics - Pediatric Endocrinology
American Board of Pediatrics - Pediatrics

Assistant Clinical Professor, Department of Pediatrics, University of Connecticut School of Medicine

  • Ardeshirpour L, Dann P, Douglas J. Adams DJ, Nelson T, VanHouten J, Horowitz MC, Wysolmerski JJ. Weaning Triggers a Decrease in RANKL Expression, Widespread Osteoclast Apoptosis and Rapid Recovery of Bone Mass after Lactation in Mice. Endocrinology, 2007 Aug; 148(8):3875-86.
  • Ardeshirpour L, Cole DEC, Carpenter TO. Evaluation of Bone and Mineral Disorders. Pediatric Endocrinology Review. Oct 2007;5 Supp1:584-98.
  • Ardeshirpour L, Qing H, Divieti Pajevic P, Dusevich V, Jähn K, Kato S, Wysolmerski J, Bonewald L
    Demonstration of Osteocytic Perilacunar/Canalicular Remodeling in Mice during Lactation, Journal of Bone and Mineral Research, 2012 May;27(5):1018-29
  • Laleh Ardeshirpour, Cristina Dumitru, Pamela Dann, John Sterpka, Joshua VanHouten, Wonnam Kim, Paul Kostenuik and John Wysolmerski. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism, Endocrinology. 2015 Aug;156(8):2762-73
  • Ardeshirpour L, Carpenter TO, Cemre Robinson
    Hypercalcaemic and hypocalcaemic syndromes in children, Chapter 4.7, Oxford Textbook of Endocrinology, Oxford, UK: Oxford University Press. 2022

Locations for this Doctor

Exterior view of 4 Corporate Drive in Shelton

Connecticut Children’s Specialty Care Center – Shelton (4 Corporate Dr.)

4 Corporate Drive, Suite 282
Shelton, CT06484
United States

4.8
out of 5

Provider showed concern

4.7

Provider explained things clearly

4.9

Provider included you in decisions

4.9

Provider discussed treatment options

4.9

Likelihood of recommending this provider

4.7